Page 39 - Circulation Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The #1 Best Food to Eat for Diabetics, According to a Dietitian © Provided by Eat This, Not That! Young woman measures blood sugar level. Diabetes affects an estimated 34.2 million people in the U.S., or 10.5% of the country's total population, according to the Centers for Disease Control and Prevention's National Diabetes Statistics Report 2020. For those with the condition, carefully monitored food intake is essential to staying healthy and reducing potential complications. Fortunately, there's one food you may already have on hand that experts consider a near-perfect addition to your d...

Amazon Appeases FDA Removes Sulfur-Based Dietary Supplement From Online Offerings Because It Cures COVID-19 And Threatens Vaccine Emergency-Use Provisions. Late last year (2020) the FDA issued a warning letter that a sulfur-based dietary supplement couldn’t be lawfully marketed because it was first studied as a drug in 1963 and marketed in that same year under the trade name Mucomyst to break up mucus accumulation in the upper respiratory tract (bronchus, lung). The dietary supplement industry legally challenged the FDA over this categorical restriction for use solely as a drug to treat dise...

About the author: Mike Adams (aka the “Health Ranger“) is a best selling author (#1 best selling science book on Amazon.com called “Food Forensics“), an environmental scientist, a patent holder for a cesium radioactive isotope elimination invention, a multiple award winner for outstanding journalism, a science news publisher and influential commentator on topics ranging from science and medicine to culture and politics. Follow his videos, podcasts, websites and science projects at the links below. Mike Adams serves as the founding editor of NaturalNews.com and the lab science director...

/PRNewswire/ -- Novo Nordisk today presented results from RESCUE, a phase 2 randomised, double-blind, placebo controlled clinical trial assessing the effect of...

/PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced the results of a new meta-analysis of seven interventional Phase 3 clinical trials...